Finding 1057256 (2020-005)

Significant Deficiency Repeat Finding
Requirement
I
Questioned Costs
-
Year
2020
Accepted
2024-08-09

AI Summary

  • Core Issue: AAPT did not follow procurement policies, leading to missing documentation for bids and selection processes.
  • Impacted Requirements: Compliance with 2 CFR 200.317-326, which mandates cost or price analysis for all procurement actions.
  • Recommended Follow-Up: Ensure all procurement records include selection justification and document compliance with updated policies by 04/15/2024.

Finding Text

Finding 2020-005: Procurement Federal Programs: Research and Development Cluster: All Grants Criteria or Specific Requirement (Including Statutory, Regulatory, or Other Citation): Procedures articulated in 2 CFR 200.317-326, requires that for all procurement of goods and services, some form of cost or price analysis shall be made and documented in the procurement files in connection with every procurement action based on the dollar thresholds sited in the compliance code. Condition: AAPT did not consistently adhere to written policies with respect to the procurement process, as bids/quotes were not obtainable or the conclusion for selection was not documented. Cause: AAPT’s internal policies and procedures governing procurement were not consistently applied. Effect or Potential Effect: Without proper and complete procurement documentation, there is a risk that AAPT will not perform proper evaluation of each element of cost to determine reasonableness. Questioned Costs: None noted. Context: Our audit procedures consisted of internal control testwork over the cash disbursement cycle over a sample population of expenditures. We consider our sample to be representative of the population. The condition appeared to be systematic in nature. Identification as a Repeat Finding, if Applicable: 2019-004. Recommendation: We recommend that all procurement records for purchases in excess of the purchase threshold include the following, at a minimum: (a) basis for contractor/goods selection or (b) justification for lack of competition when competitive bids or offers are not obtained. Additionally, the conclusion should be clearly documented and accompanying the procurement documentation. Views of Responsible Officials and Planned Corrective Actions: Management will update current policies and procedures and review and enforce the polices. Management will be responsible for proper documentation and confirmation that all policies and procedures are followed. Management will confirm that all agreements, mou’s and contracts are property, reviewed signed and documented. Management will require all departments to document all procurements for goods and services with written cost and price analysis based on AAPT's dollar thresholds. Anticipated Completion Date: 04/15/2024 Responsible Official: Dr. Beth Cunningham CEO, Michael Brosnan CFO

Categories

Procurement, Suspension & Debarment

Other Findings in this Audit

  • 480780 2020-003
    Material Weakness Repeat
  • 480781 2020-005
    Significant Deficiency Repeat
  • 480782 2020-003
    Material Weakness Repeat
  • 480783 2020-005
    Significant Deficiency Repeat
  • 480784 2020-003
    Material Weakness Repeat
  • 480785 2020-004
    Significant Deficiency
  • 480786 2020-005
    Significant Deficiency Repeat
  • 480787 2020-003
    Material Weakness Repeat
  • 480788 2020-004
    Significant Deficiency
  • 480789 2020-005
    Significant Deficiency Repeat
  • 480790 2020-003
    Material Weakness Repeat
  • 480791 2020-005
    Significant Deficiency Repeat
  • 480792 2020-006
    Significant Deficiency Repeat
  • 480793 2020-003
    Material Weakness Repeat
  • 480794 2020-005
    Significant Deficiency Repeat
  • 480795 2020-003
    Material Weakness Repeat
  • 480796 2020-004
    Significant Deficiency
  • 480797 2020-005
    Significant Deficiency Repeat
  • 480798 2020-003
    Material Weakness Repeat
  • 480799 2020-005
    Significant Deficiency Repeat
  • 480800 2020-003
    Material Weakness Repeat
  • 480801 2020-005
    Significant Deficiency Repeat
  • 480802 2020-003
    Material Weakness Repeat
  • 480803 2020-005
    Significant Deficiency Repeat
  • 480804 2020-003
    Material Weakness Repeat
  • 480805 2020-005
    Significant Deficiency Repeat
  • 480806 2020-003
    Material Weakness Repeat
  • 480807 2020-005
    Significant Deficiency Repeat
  • 480808 2020-003
    Material Weakness Repeat
  • 480809 2020-005
    Significant Deficiency Repeat
  • 480810 2020-003
    Material Weakness Repeat
  • 480811 2020-005
    Significant Deficiency Repeat
  • 480812 2020-003
    Material Weakness Repeat
  • 480813 2020-005
    Significant Deficiency Repeat
  • 480814 2020-005
    Significant Deficiency Repeat
  • 480815 2020-005
    Significant Deficiency Repeat
  • 480816 2020-005
    Significant Deficiency Repeat
  • 1057222 2020-003
    Material Weakness Repeat
  • 1057223 2020-005
    Significant Deficiency Repeat
  • 1057224 2020-003
    Material Weakness Repeat
  • 1057225 2020-005
    Significant Deficiency Repeat
  • 1057226 2020-003
    Material Weakness Repeat
  • 1057227 2020-004
    Significant Deficiency
  • 1057228 2020-005
    Significant Deficiency Repeat
  • 1057229 2020-003
    Material Weakness Repeat
  • 1057230 2020-004
    Significant Deficiency
  • 1057231 2020-005
    Significant Deficiency Repeat
  • 1057232 2020-003
    Material Weakness Repeat
  • 1057233 2020-005
    Significant Deficiency Repeat
  • 1057234 2020-006
    Significant Deficiency Repeat
  • 1057235 2020-003
    Material Weakness Repeat
  • 1057236 2020-005
    Significant Deficiency Repeat
  • 1057237 2020-003
    Material Weakness Repeat
  • 1057238 2020-004
    Significant Deficiency
  • 1057239 2020-005
    Significant Deficiency Repeat
  • 1057240 2020-003
    Material Weakness Repeat
  • 1057241 2020-005
    Significant Deficiency Repeat
  • 1057242 2020-003
    Material Weakness Repeat
  • 1057243 2020-005
    Significant Deficiency Repeat
  • 1057244 2020-003
    Material Weakness Repeat
  • 1057245 2020-005
    Significant Deficiency Repeat
  • 1057246 2020-003
    Material Weakness Repeat
  • 1057247 2020-005
    Significant Deficiency Repeat
  • 1057248 2020-003
    Material Weakness Repeat
  • 1057249 2020-005
    Significant Deficiency Repeat
  • 1057250 2020-003
    Material Weakness Repeat
  • 1057251 2020-005
    Significant Deficiency Repeat
  • 1057252 2020-003
    Material Weakness Repeat
  • 1057253 2020-005
    Significant Deficiency Repeat
  • 1057254 2020-003
    Material Weakness Repeat
  • 1057255 2020-005
    Significant Deficiency Repeat
  • 1057257 2020-005
    Significant Deficiency Repeat
  • 1057258 2020-005
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
47.049 Mathematical and Physical Sciences $10,562
47.076 Education and Human Resources $6,442
43.001 Science $4,172